Masimo Corporation (MASI)
Jun 10, 2026 - MASI was delisted (reason: acquired by DHR)
179.95
+0.01 (0.01%)
Inactive · Last trade price on Jun 9, 2026
Masimo Revenue
Masimo had revenue of $403.60M in the quarter ending April 4, 2026, a decrease of -32.81%. This brings the company's revenue in the last twelve months to $1.72B, up 8.85% year-over-year. In the year 2024, Masimo had annual revenue of $2.09B with 2.26% growth.
Revenue (ttm)
$1.72B
Revenue Growth
+8.85%
P/S Ratio
6.05
Revenue / Employee
$708,409
Employees
2,200
Market Cap
9.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 2.09B | 46.30M | 2.26% |
| Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
| Dec 31, 2022 | 2.04B | 796.60M | 64.28% |
| Jan 1, 2022 | 1.24B | 95.50M | 8.35% |
| Jan 2, 2021 | 1.14B | 205.86M | 21.95% |
| Dec 28, 2019 | 937.84M | 79.55M | 9.27% |
| Dec 29, 2018 | 858.29M | 68.04M | 8.61% |
| Dec 30, 2017 | 790.25M | 95.62M | 13.77% |
| Dec 31, 2016 | 694.63M | 64.51M | 10.24% |
| Jan 2, 2016 | 630.11M | 43.47M | 7.41% |
| Jan 3, 2015 | 586.64M | 39.40M | 7.20% |
| Dec 28, 2013 | 547.25M | 54.01M | 10.95% |
| Dec 29, 2012 | 493.23M | 54.25M | 12.36% |
| Dec 31, 2011 | 438.99M | 33.58M | 8.28% |
| Jan 1, 2011 | 405.41M | 56.29M | 16.12% |
| Jan 2, 2010 | 349.12M | 42.04M | 13.69% |
| Jan 3, 2009 | 307.07M | 50.79M | 19.82% |
| Dec 29, 2007 | 256.29M | 31.95M | 14.24% |
| Dec 31, 2006 | 224.34M | 116.45M | 107.93% |
| Dec 31, 2005 | 107.89M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMASI News
- 11 days ago - Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner - Business Wire
- 2 months ago - Masimo Shareholders Approve Acquisition by Danaher - Business Wire
- 2 months ago - Masimo Transcript: EGM 2026 - Transcripts
- 2 months ago - Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study - Business Wire
- 2 months ago - Masimo Proxy statement: Proxy filing - Filings
- 3 months ago - Masimo Proxy statement: Proxy filing - Filings
- 3 months ago - Masimo Proxy statement: Proxy Filing - Filings
- 4 months ago - Masimo Annual report: Q4 2025 - Filings